Go to ...

Boston News Globe

News Network

RSS Feed

September 21, 2018

Money

Shire wins FDA approval for potential blockbuster rare disease drug

The FDA has approved a potential blockbuster rare disease drug developed by Shire plc, which is set to be absorbed by Takeda Pharmaceuticals next year. The drug, Takhzyro, treats a rare and potentially life-threatening genetic disease called hereditary angioedema, or HAE, which leads to episodes of swelling in the limbs, abdomen and airway. Shire’s (Nasdaq:

Head of Mass. credit union lobbying group to step down

Paul Gentile is leaving his post as head of the Cooperative Credit Union Association, the Marlborough-based organization that advocates for credit unions in Massachusetts and three other states, to run a New Jersey credit union. The CCUA board will conduct a nationwide search for Gentile’s successor, according to a statement earlier this week. Gentile helped

Tontine Crescent, a model for small public spaces in Boston, opens

The city held a kickoff ceremony Friday morning for the opening of a small urban park in the city’s Financial District called the Tontine Crescent. Nestled in the curve of Franklin Street, the new plaza was dreamed up by Millennium Partners, the Boston Transportation Department and the Downtown Boston Business Improvement District. The small park,

Just-opened Pier 4 office building sells for 'record' price

CommonWealth Partners has purchased the Pier 4 office building in the Seaport, built by Tishman Speyer and just opened this summer, for what it says is a record-setting price of $1,208 per square foot. In May, the Business Journal reported that the 13-story office building near the former home of legendary Boston seafood restaurant Anthony’s

Older Posts››